Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04848337
Brief Title: Pembrolizumab and Lenvatinib in Advanced/Metastatic Neuroendocrine Prostate Cancer (PLANE-PC)

First Submitted : April 9, 2021
First Submitted that Met QC Criteria : April 13, 2021
First Posted : April 19, 2021

Last Update Submitted that Met QC Criteria : July 12, 2021
Last Update Posted : July 16, 2021